目的评测病人健康问卷-9(patient health questionnaire-9,PHQ-9)在我国脑卒中人群中的信度和效度。方法由经过培训的4名调查员对156例脑卒中患者分别进行Beck抑郁自评量表(Beck depression inventory,BDI)和PHQ-9、汉密尔顿抑郁量表(Ha...目的评测病人健康问卷-9(patient health questionnaire-9,PHQ-9)在我国脑卒中人群中的信度和效度。方法由经过培训的4名调查员对156例脑卒中患者分别进行Beck抑郁自评量表(Beck depression inventory,BDI)和PHQ-9、汉密尔顿抑郁量表(Hamilton depression rating scale,HAMD)和世界卫生组织复合性国际诊断访谈表3.0(World Health Organization composite international diagnostic interview,WHO-CIDI3.0)的评测,分析PHQ-9应用于脑卒中患者的信度、效度。结果克朗巴赫α系数为0.8383,提示该量表内部一致性较好;条目与总分的相关系数为0.533～0.777(P<0.05),各条目间的相关系数为0.183～0.599,提示该量表内部一致性较好;PHQ-9的效标效度为0.599(P<0.01),提示该量表效标效度良好;PHQ-9与BDI的相关系数为0.803(P<0.01),与HAMD的相关系数为0.835(P<0.01),提示该量表结构效度良好。结论 PHQ-9具有良好的信度和效度,基本符合心理测量学标准,是评价卒中后抑郁的可靠、有效工具。展开更多
Purpose: To determine the incidence of depression among pregnant women during the coronavirus disease (COVID-19) pandemic. Methods: A literature search was conducted on July 2022 through PubMed, CINAHL, MEDLINE, CiNii...Purpose: To determine the incidence of depression among pregnant women during the coronavirus disease (COVID-19) pandemic. Methods: A literature search was conducted on July 2022 through PubMed, CINAHL, MEDLINE, CiNii, and the Japan Medical Abstract Society using the keywords “COVID-19”, “Pregnant Women” and “Depression”. The titles/abstracts were screened based on three selection criteria: 1) inclusion of pregnant women;2) description of depression;3) description of COVID-19. Results: Of the 213 articles that were extracted, 104 were excluded owing to duplication and 14 were excluded because they comprised other article types, including reviews and commentaries. Finally, 49 were excluded by title, abstract, and full-text screening. Among the 46 articles that met the inclusion criteria, 13 articles (28.3%) were from China, 8 (17.4%) were from Turkey, 4 (8.7%) were from the United States, and 3 (6.5%) were from Japan. The most common scales used to measure depression were the Edinburgh Postnatal Depression Scale (EPDS) used in 18 articles (39.1%), followed by the Patient Health Questionnaire (PHQ-9) used in 11 articles (23.9%). Furthermore, 46 sources reported a suspected depression rate of 30.0% (20,338/67,860 pregnant women). The rate of depression was 15.1% - 33.5% using EPDS ≥ 9 in three articles and 12.0% - 43.2% using EPDS ≥ 13 in nine articles. The five articles using PHQ-9 ≥ 5 reported 25.8% - 48.7%, and seven articles reported 5.3% - 59.2% using PHQ-9 ≥ 10. Conclusion: Depression was a concern for one out of every three to four pregnant women during the COVID-19 pandemic. This suggests that depression among pregnant women during COVID-19 might have worsened, highlighting the need for mental health support for them.展开更多
目的检验中文版患者健康问卷（patient health questionnaire,PHQ）中抑郁症状群量表（PHQ-9）在综合性医院普通门诊患者中的信度、效度和检出率。方法600例综合性医院普通门诊患者完成中文版PHQ-9和医院焦虑抑郁量表（hospital anxiety...目的检验中文版患者健康问卷（patient health questionnaire,PHQ）中抑郁症状群量表（PHQ-9）在综合性医院普通门诊患者中的信度、效度和检出率。方法600例综合性医院普通门诊患者完成中文版PHQ-9和医院焦虑抑郁量表（hospital anxiety and depression scale,HADS）自评,并接受汉密顿抑郁量表（hamilton depression scale,HAMD）的评定,抽取44名患者在完成初次评定后7-14 d内接受PHQ-9重测;抽取96例患者,在完成初次评定后2周内,接受专业研究人员的定式临床精神检查（structured clinical interview for DSM-IV,SCID）。结果PHQ-9内部一致性系数为0.857,条目间的相关系数为0.236-0.718,各条目与量表总分的相关系数为0.588-0.784,先后两次测定总分的相关系数为0.947,PHQ-9总分与HADS总分及抑郁分量表分值和HAMD总分的相关系数范围0.792-0.811,PHQ-9的灵敏度为91%,特异度为97%,Kappa=0.884。检出抑郁症状群98例,占总样本量的16.3%（95%CI：13.4%-19.3%）。结论中文版本PHQ-9在综合性医院普通门诊患者应用中具有良好的信度和效度。展开更多
文摘目的评测病人健康问卷-9(patient health questionnaire-9,PHQ-9)在我国脑卒中人群中的信度和效度。方法由经过培训的4名调查员对156例脑卒中患者分别进行Beck抑郁自评量表(Beck depression inventory,BDI)和PHQ-9、汉密尔顿抑郁量表(Hamilton depression rating scale,HAMD)和世界卫生组织复合性国际诊断访谈表3.0(World Health Organization composite international diagnostic interview,WHO-CIDI3.0)的评测,分析PHQ-9应用于脑卒中患者的信度、效度。结果克朗巴赫α系数为0.8383,提示该量表内部一致性较好;条目与总分的相关系数为0.533～0.777(P<0.05),各条目间的相关系数为0.183～0.599,提示该量表内部一致性较好;PHQ-9的效标效度为0.599(P<0.01),提示该量表效标效度良好;PHQ-9与BDI的相关系数为0.803(P<0.01),与HAMD的相关系数为0.835(P<0.01),提示该量表结构效度良好。结论 PHQ-9具有良好的信度和效度,基本符合心理测量学标准,是评价卒中后抑郁的可靠、有效工具。
文摘Purpose: To determine the incidence of depression among pregnant women during the coronavirus disease (COVID-19) pandemic. Methods: A literature search was conducted on July 2022 through PubMed, CINAHL, MEDLINE, CiNii, and the Japan Medical Abstract Society using the keywords “COVID-19”, “Pregnant Women” and “Depression”. The titles/abstracts were screened based on three selection criteria: 1) inclusion of pregnant women;2) description of depression;3) description of COVID-19. Results: Of the 213 articles that were extracted, 104 were excluded owing to duplication and 14 were excluded because they comprised other article types, including reviews and commentaries. Finally, 49 were excluded by title, abstract, and full-text screening. Among the 46 articles that met the inclusion criteria, 13 articles (28.3%) were from China, 8 (17.4%) were from Turkey, 4 (8.7%) were from the United States, and 3 (6.5%) were from Japan. The most common scales used to measure depression were the Edinburgh Postnatal Depression Scale (EPDS) used in 18 articles (39.1%), followed by the Patient Health Questionnaire (PHQ-9) used in 11 articles (23.9%). Furthermore, 46 sources reported a suspected depression rate of 30.0% (20,338/67,860 pregnant women). The rate of depression was 15.1% - 33.5% using EPDS ≥ 9 in three articles and 12.0% - 43.2% using EPDS ≥ 13 in nine articles. The five articles using PHQ-9 ≥ 5 reported 25.8% - 48.7%, and seven articles reported 5.3% - 59.2% using PHQ-9 ≥ 10. Conclusion: Depression was a concern for one out of every three to four pregnant women during the COVID-19 pandemic. This suggests that depression among pregnant women during COVID-19 might have worsened, highlighting the need for mental health support for them.
文摘目的检验中文版患者健康问卷（patient health questionnaire,PHQ）中抑郁症状群量表（PHQ-9）在综合性医院普通门诊患者中的信度、效度和检出率。方法600例综合性医院普通门诊患者完成中文版PHQ-9和医院焦虑抑郁量表（hospital anxiety and depression scale,HADS）自评,并接受汉密顿抑郁量表（hamilton depression scale,HAMD）的评定,抽取44名患者在完成初次评定后7-14 d内接受PHQ-9重测;抽取96例患者,在完成初次评定后2周内,接受专业研究人员的定式临床精神检查（structured clinical interview for DSM-IV,SCID）。结果PHQ-9内部一致性系数为0.857,条目间的相关系数为0.236-0.718,各条目与量表总分的相关系数为0.588-0.784,先后两次测定总分的相关系数为0.947,PHQ-9总分与HADS总分及抑郁分量表分值和HAMD总分的相关系数范围0.792-0.811,PHQ-9的灵敏度为91%,特异度为97%,Kappa=0.884。检出抑郁症状群98例,占总样本量的16.3%（95%CI：13.4%-19.3%）。结论中文版本PHQ-9在综合性医院普通门诊患者应用中具有良好的信度和效度。
